GNH USA

Europe — EMA

Metex Pen

GNH USA supplies Metex Pen (Methotrexate), a disease-modifying antirheumatic drug for rheumatoid arthritis, psoriasis and certain cancers.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Metex Pen, is an antimetabolite (folate antagonist) presented as a pre‑filled pen for subcutaneous injection use. It is employed to modify disease activity in rheumatoid arthritis, psoriasis, certain malignancies and ectopic pregnancy. GNH USA supplies Metex Pen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is indicated for several autoimmune and oncologic conditions, acting as a disease‑modifying agent. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: decreases skin plaque formation and severity. - Acute lymphoblastic leukemia and non‑Hodgkin lymphoma: interferes with malignant cell proliferation. - Ectopic pregnancy: terminates trophoblastic tissue when surgery is not indicated.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea or vomiting: mild to moderate gastrointestinal upset. - Fatigue: persistent tiredness not relieved by rest. - Oral ulceration: sores or inflammation of the mouth lining. - Elevated liver enzymes: mild, transient increase in hepatic function tests. - Cytopenias: mild reductions in white blood cells or platelets. - Headache: occasional mild to moderate pain.

Serious or Rare Side Effects: - Severe hepatotoxicity: significant liver injury requiring monitoring. - Pulmonary fibrosis: progressive lung scarring with breathlessness. - Bone marrow aplasia: profound suppression of blood cell production. - Renal failure: acute kidney injury especially with dehydration. - Severe infection: opportunistic infections due to immunosuppression. - Life‑threatening skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

What precautions apply to Methotrexate?

Methotrexate requires careful monitoring and specific safety measures before and during therapy. - Pregnancy: contraindicated (Category X); teratogenic risk mandates effective contraception. - Renal function: assess baseline creatinine and adjust dose in impairment. - Hepatic function: obtain baseline liver enzymes and monitor regularly. - Hematologic monitoring: perform complete blood counts before each dose. - Drug interactions: avoid concurrent high‑dose NSAIDs and certain antibiotics that increase toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate can interact with several medicines, altering its safety profile.

Major Interactions (Avoid): - Live vaccines: heightened risk of severe infection. - Trimethoprim‑sulfamethoxazole: additive bone‑marrow suppression. - Azathioprine: combined myelosuppressive effect.

Moderate Interactions (Monitor Closely): - NSAIDs (high dose): may increase renal toxicity. - Proton pump inhibitors: potential alteration of absorption. - Alcohol: can exacerbate hepatic injury.

Frequently asked questions

What is Metex Pen used for?+
Metex Pen contains methotrexate and is prescribed for rheumatoid arthritis, moderate to severe plaque psoriasis, certain hematologic cancers such as acute lymphoblastic leukemia and non‑Hodgkin lymphoma, and for medical management of ectopic pregnancy when surgery is not preferred.
How does methotrexate work?+
Methotrexate blocks the enzyme dihydrofolate reductase, preventing the formation of tetrahydrofolate needed for DNA synthesis. This limits the proliferation of rapidly dividing cells, including immune cells that drive inflammation and malignant cells, while also increasing extracellular adenosine that has anti‑inflammatory properties.
What determines the dose of Metex Pen?+
The dose of Metex Pen is individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal and hepatic function, and response to therapy. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.
Is Metex Pen safe during pregnancy or breastfeeding?+
Methotrexate is classified as Pregnancy Category X because it is known to cause fetal malformations and embryotoxicity. It is contraindicated in pregnancy and should be stopped well before conception. Breastfeeding is also not recommended, as methotrexate can be excreted in milk and affect the infant.
How do I order Metex Pen from GNH USA?+
To request Metex Pen, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and the necessary import documentation.
How does Metex Pen compare with other methotrexate products or alternative DMARDs?+
Metex Pen offers a pre‑filled subcutaneous delivery system, which can improve patient convenience and absorption compared with oral tablets that have variable bioavailability. Compared with biologic DMARDs, methotrexate is less costly but requires regular laboratory monitoring. Efficacy is comparable for many patients with rheumatoid arthritis, while safety profiles differ.
How should Metex Pen be stored and handled?+
Metex Pen must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the pen in its original packaging until use, and discard any product that has been exposed to temperatures outside this range.
How is Metex Pen administered?+
Metex Pen is a pre‑filled pen designed for subcutaneous injection. After selecting the prescribed dose, the user or healthcare professional removes the safety cap, cleans the injection site, and presses the activation button to deliver the medication into the subcutaneous tissue, typically in the abdomen or thigh.
What are the most serious risks to watch for while using Metex Pen?+
Serious risks include severe liver toxicity, pulmonary fibrosis, profound bone‑marrow suppression leading to pancytopenia, acute renal failure, life‑threatening infections, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they develop jaundice, persistent cough, unexplained fever, bleeding, or severe skin rash.
Who should not use Metex Pen?+
Metex Pen is contraindicated in pregnant women, individuals with known hypersensitivity to methotrexate, patients with severe renal or hepatic impairment, and those with existing bone‑marrow failure. Caution is also advised for patients with active infections, pulmonary disease, or those receiving other myelosuppressive agents.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU